Fregnani ER, Leite AA, Parahyba CJ, Nesrallah ACA, Ramos-Perez FMM, Cruz Perez DEC. Mandibular destructive radiolucent lesion: The first sign of multiple myeloma. J Clin Exp Dent. 2016;8(4):e465-8.

 

doi:10.4317/jced.52832

http://dx.doi.org/doi:10.4317/jced.52832

 

References

1. Vieira-Leite-Segundo A, Lima Falcão MF, Correia-Lins Filho R, Marques Soares MS, López López J, Chimenos Küstner A. Multiple myeloma with primary manifestation in the mandible: a case report. Med Oral Patol Oral Cir Bucal. 2008;13:232-4.

PMid:18379446

 

2. Souza LN, Farias LC, Santos LA, Mesquita RA, Martelli H Jr, De-Paula AM. Asymptomatic expansile lesion of the posterior mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:4-7.
http://dx.doi.org/10.1016/j.tripleo.2006.06.051
PMid:17178487

 

3. Stoopler ET, Vogl DT, Stadtmauer EA. Medical management update: multiple myeloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:599-609.
http://dx.doi.org/10.1016/j.tripleo.2006.10.026
PMid:17291793

 

4 . Elias HG, Scott J, Metheny L, Quereshy FA. Multiple myeloma presenting as mandibular ill-defined radiolucent lesion with numb chin syndrome: a case report. J Oral Maxillofac Surg. 2009;67:1991-6.
http://dx.doi.org/10.1016/j.joms.2009.04.016
PMid:19686938

 

5 . An SY, An CH, Choi KS, Heo MS. Multiple myeloma presenting as plasmacytoma of the jaws showing prominent bone formation during chemotherapy. Dentomaxillofac Radiol. 2013;42:1-6.
http://dx.doi.org/10.1259/dmfr.20110143
PMid:23520399 PMCid:PMC3667514

 

6. Rajkumar SV. Treatment of multiple myeloma. Nat Rev Clin Oncol. 2011;8:479-81.
http://dx.doi.org/10.1038/nrclinonc.2011.63
PMid:21522124 PMCid:PMC3773461

 

7. Pushpanshu K, Punyani S, Kaushik R. Mandibular mass as the primary manifestation of multiple myeloma. Braz J Otorhinolaryngol. 2014;80:266-7.
http://dx.doi.org/10.1016/j.bjorl.2013.01.001
PMid:25153114

 

8. Pisano JJ, Coupland R, Chen SY, Miller AS. Plasmacytoma of the oral cavity and jaws: a clinicopathologic study of 13 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:265-71.
http://dx.doi.org/10.1016/S1079-2104(97)90015-9

PMid:9117760

 

9. Wei H, Pinting L, Enyi T, Zhiyong W. Initial finding of mandible mass in multiple myeloma. J Craniofac Surg. 2013;23:599-600.
http://dx.doi.org/10.1097/SCS.0b013e31826bf44c
PMid:23172490

 

10. Rajkumar SV. Multiple myeloma: 2014 update on diagnosis, risk stratification, and management. Am J Hematol. 2014;89:999-1009.
http://dx.doi.org/10.1002/ajh.23810
PMid:25223428

 

11. Roodman GD. Pathogenesis of myeloma bone disease. Leukemia. 2009;23:435-41.
http://dx.doi.org/10.1038/leu.2008.336

PMid:19039321

 

12. Edwards CM, Zhuang J, Mundy GR. The pathogenesis of the bone disease of multiple myeloma. Bone. 2008;42:1007-13.
http://dx.doi.org/10.1016/j.bone.2008.01.027
PMid:18406675 PMCid:PMC2474770

 

13. Pinto LS, Campagnoli EB, Leon JE, Lopes MA, Jorge J. Maxillary lesion presenting as a first sign of multiple myeloma: case report. Med Oral Patol Oral Cir Bucal. 2007;12:344-7.

PMid:17767095

 

14. Da Silva Santos PS, Klingbeil MF, Abrahao AC, Gallottini M, De Sousa SC. Multiple myeloma with primary manifestation in mandibular area. Oral Surg. 2012;5:26-9.
http://dx.doi.org/10.1111/j.1752-248X.2011.01141.x

 

15. Rajkumar SV, Gahrton G, Bergsagel PL. Approach to the treatment of multiple myeloma: a clash of philosophies. Blood. 2011;118:3205-11.
http://dx.doi.org/10.1182/blood-2011-06-297853
PMid:21791430 PMCid:PMC3179390

 

16. Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol. 2006;24:945-52.
http://dx.doi.org/10.1200/JCO.2005.04.2465
PMid:16484704

 

17. Mozaffari E, Mupparapu M, Otis L. Undiagnosed multiple myeloma causing extensive dental bleeding: report of a case and review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:448-53.
http://dx.doi.org/10.1067/moe.2002.125201
PMid:12374918

 

18. Canger EM, Celenk P, Alkan A, Günhan O. Mandibular involvement of solitary plasmocytoma: a case report. Med Oral Patol Oral Cir Bucal. 2007;12:7-9.

PMid:17195833

 

19. Chang WJ, Kang ES, Lee ST, Kim SH, Kim DW, Kim SJ, et al. Thalidomide, cyclophosphamide and dexamethasone induction therapy: feasibility for myeloma patients destined for autologous stem cell transplantation. Acta Haematol. 2014;132:226-32.
http://dx.doi.org/10.1159/000357659
PMid:24732093